跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 13,291 条关于
“Hansoh Pharmaceutical”
全部
13,291
临床试验
550
药物
1,664
机构
2,172
资讯
8,905
去年
Hansoh Pharma's HS-20093 Granted Breakthrough Therapy Designation for Lung Cancer
去年
Hansoh Pharma's Aumolertinib Plus Chemotherapy Shows Positive Phase III Results in EGFR-Mutated NSCLC
去年
Hansoh Pharma's HS-20093 ADC Granted Breakthrough Therapy Designation for ES-SCLC
去年
Hansoh Pharmaceutical Says NMPA Granted Drug Registration Approval Of Third Indication ...
8个月前
Hansoh Pharmaceutical's Aumolertinib Receives EU Approval for Advanced NSCLC Treatment
11个月前
China's NMPA Accepts Hansoh Pharmaceutical's RET Inhibitor Application for Lung Cancer Treatment
去年
Hansoh Pharma's HS-20093 Receives Breakthrough Therapy Designation in China for Small Cell Lung Cancer
5个月前
Tortugas Neuroscience Emerges from Stealth with $106M to Advance CNS Drug Pipeline Licensed from Eisai and Hansoh
去年
Hansoh Pharma's HS-20093 ADC Granted Breakthrough Therapy Designation for SCLC in China
9个月前
Glenmark Secures Global Rights to Third-Generation EGFR-TKI Aumolertinib for Lung Cancer Treatment
第 1 页,共 891 页
上一页
下一页